Neumind is a UK-based startup founded in 2020, dedicated to improving the lives of individuals with cognitive impairments. The company's slogan, "Improving the lives of those living with cognitive impairments," reflects its commitment to providing gold-standard neuro care in a simple and accessible manner within the Digital Health and Health Care industries.
The startup recently secured a noteworthy $100.00K grant investment on 08 February 2023, with backing from Harvard Innovation Labs. This investment not only demonstrates confidence in Neumind's mission but also provides vital support for the development and implementation of their innovative solutions.
Neumind's ongoing efforts to enhance cognitive care could have far-reaching implications, making it a compelling prospect for venture capital firms seeking impactful healthcare and technology investments. The startup's focus on simplifying access to gold-standard neuro care presents a valuable opportunity for investors looking to contribute to advancements in this critical sector.